Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’
SoftBank Vision Fund 2, Alaska Permanent Fund Corporation, Altitude Life Science Ventures, Qatar Investment Authority, and Other New...